JERZY GAJEWSKI, M.D., PH.D.
To the editor: Thrombolytic therapy for peripheral vein thrombosis has recently aroused wide interest (1-3). This approach is considered to be relatively safe, with only mild side effects. Although, theoretically, the significantly enhanced fibrinolytic activity—in the presence of a massive fresh venous thrombosis—could favor pulmonary embolization, in practice this does not seem to be a common complication. The following case, however, indicates that such a complication represents a real possibility:
A 52-year-old saleswoman was admitted to the hospital(A 52-year-old saleswoman was admitted to the hospital* because of marked painful swelling of her right leg. Two days before admission she first noticed moderate pain in the posterior region) because of marked painful swelling of her right leg. Two days before admission she first noticed moderate pain in the posterior region
Learn more about subscription options.
Register Now for a free account.
GAJEWSKI J. Thrombolytic Therapy and Fatal Massive Pulmonary Emboli. Ann Intern Med. 1971;74:450. doi: 10.7326/0003-4819-74-3-450_1
Download citation file:
Published: Ann Intern Med. 1971;74(3):450.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only